| Our Next Potential Breakout Headliner Is Coming Tomorrow Morning—Thursday, October 30, 2025, Before The Bell
Set Your Alarm For 8:00 AM EST
For Those Who Have Been Following Me For A While—This Could Be The One You’ve Been Waiting For.
Here’s What We Can Tell You Tonight…
A Tiny Float: Fewer Than 9M Shares Available — Early Demand Could Lead To The Potential For Big Moves
Still Under The Radar: Trending Near $1 And Largely Unnoticed — For Now Analyst Coverage: New Report Published Today Set A $12 Target Which Suggests 1,100% Upside Potential
Take 2 Minutes Now to Connect with Us on all of Our No-Cost Platforms! (See instructions below)
October 29, 2025
Dear Reader,
Tomorrow morning — Thursday, October 30, 2025, before the opening bell rings — we’re unveiling a little-known MedTech company that just landed on our morning watchlist.
If you want to catch every alert the moment it drops, join us in our no-cost WhatsApp group for real-time updates — now one of our fastest-growing platforms.
What makes this one stand out?
Here’s a preview of what we’re tracking:
- A Tiny Float: Fewer than 9M shares available — when numbers are this small, early demand can move fast.
- Still Under The Radar: Currently trending near $1, this company remains largely unnoticed — for now.
- Record Growth: The company recently reported all-time-high unit sales, reflecting 60% year-over-year expansion in recurring consumable demand.
- Global Expansion: Now active across 24 countries and more than 480 accounts, with 18 distribution partners helping drive international growth.
- Regulatory Milestone Ahead: The next phase of the FDA 510(k) process is underway, with potential U.S. market clearance anticipated in the second half of 2026.
- Enterprise Traction: A newly announced contract with a multinational group employing 30,000 staff signals accelerating adoption at scale.
- Analyst Coverage: A new report published today set a $12 target, pointing to an estimated 1,100% potential move from recent levels.
|
0 Response to "Tomorrow Before The Bell: Our Next Low-Float Profile Goes Live — Here’s A Preview"
Post a Comment